| abstract |
The present invention relates to a pharmaceutical composition comprising at least one compound of formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are independently hydrogen or a group R7-CO- where R7 is an alkyl group linear, branched or cyclic alkene or alkyne comprising from 2 to 24 carbon atoms; R4 is a hydrogen atom or a mannosyl group substituted in the 6-position by a residue R6 selected from the group consisting of a hydrogen atom and a group R7-CO-; and R5 is selected from the group consisting of hydrogen, mono-, di-, tri-, tetra- and pentamannosyl; and the use of such a composition for the manufacture of a medicament for the prevention or treatment of a disease associated with overexpression of TNF and / or IL-12 in a subject. |